Jacques PFISTER
MBA
-
Previously President of "CCI Marseille Provence"
CCI Marseille Provence
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
Marseille Immunopole is one spearheads of the Aix-Marseille-Provence Metropolis excellence, in research as in the economy field.
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.
CCI Marseille Provence, already at the initiative of the Eurobiomed cluster, accompanies this ambitious metropolitan project in its entrepreneurial and international dimensions. Alongside with its institutional partners, it facilitates the development of companies and contributes to the development of this project.
Health is a major economical sector of Aix-Marseille-Provence Metropolis. Combining a high-level public and private healthcare offer with high research potential, it constitutes an expanding strategic sector for CCI Marseille Provence, which gave rise to numerous ambitious and innovative entrepreneurial initiatives.
Combined successes of Éric Vivier, a world-renowned researcher, Hervé Brailly and Vincent Fert, entrepreneurs who have both developed their companies in a remarkable way, illustrate perfectly the dynamism and the innovative capacity of our territory in this essential area.
Have a look on our testimonies
Together, we pursue a simple goal: to better understand the alterations of energetic metabolism in pancreatic cancer cells
Alice CARRIER
AMU, IPC, CRCM
Marseille Immunopole should allow us now to accelerate the development of therapeutic antibodies, the new drugs that are changing the course of cancer treatment.
Jean-Paul BORG
AMU, IPC, CRCM
Each year, a large number of clinical trials are conducted by APHM clinicians alone or in partnership with industry players in biopharmaceuticals.
Frédéric VELY
AMU, AP-HM, CIML
A therapeutic revolution is happening.
Bertrand NADEL
CIML, Canceropôle PACA
your commitment to MI